Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1945559 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ALK receptor tyrosine kinase/ALK tyrosine kinase receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4247] [GtoPdb: 1839] [UniProtKB: Q9UM73] | ||||||||
ChEMBL | Inhibition of ALK using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
calcium/calmodulin-dependent protein kinase II beta subunit/CaM kinase II beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4121] [GtoPdb: 1556] [UniProtKB: Q13554] | ||||||||
ChEMBL | Inhibition of CaMK2 using ATP as substrate | B | 7.08 | pIC50 | 83 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
casein kinase 1 alpha 1/Casein kinase I alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2793] [GtoPdb: 1995] [UniProtKB: P48729] | ||||||||
ChEMBL | Inhibition of CK1alpha using ATP as substrate | B | 6.48 | pIC50 | 330 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL301] [GtoPdb: 1973] [UniProtKB: P24941] | ||||||||
ChEMBL | Inhibition of CDK2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
cyclin dependent kinase 4/Cyclin-dependent kinase 4/cyclin D1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL1907601] [GtoPdb: 1976] [UniProtKB: P11802, P24385] | ||||||||
ChEMBL | Inhibition of CDK4/D1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
CDC like kinase 3/Dual specificity protein kinase CLK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4226] [GtoPdb: 1992] [UniProtKB: P49761] | ||||||||
ChEMBL | Inhibition of recombinant CLK3 (unknown origin) using Ac-ERMRPRKRQGSVdP(Sox)G-NH2 as substrate after 5 mins by Omnia Kinase Assay | B | 4.57 | pKi | 26900 | nM | Ki | J Med Chem (2020) 63: 10224-10234 [PMID:32787076] |
CDC like kinase 1/Dual specificty protein kinase CLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4224] [GtoPdb: 1990] [UniProtKB: P49759] | ||||||||
ChEMBL | Inhibition of full length wild type CLK1 (unknown origin) expressed in HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay | B | 6.85 | pKi | 140 | nM | Ki | J Med Chem (2020) 63: 10224-10234 [PMID:32787076] |
EPH receptor A4/Ephrin type-A receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3988] [GtoPdb: 1824] [UniProtKB: P54764] | ||||||||
ChEMBL | Inhibition of EphA4 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
EPH receptor B4/Ephrin type-B receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5147] [GtoPdb: 1833] [UniProtKB: P54760] | ||||||||
ChEMBL | Inhibition of EphB4 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of HER1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
fibroblast growth factor receptor 1/Fibroblast growth factor receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3650] [GtoPdb: 1808] [UniProtKB: P11362] | ||||||||
ChEMBL | Inhibition of FGFR1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
fibroblast growth factor receptor 2/Fibroblast growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4142] [GtoPdb: 1809] [UniProtKB: P21802] | ||||||||
ChEMBL | Inhibition of FGFR2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
fibroblast growth factor receptor 3/Fibroblast growth factor receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2742] [GtoPdb: 1810] [UniProtKB: P22607] | ||||||||
ChEMBL | Inhibition of FGFR3 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
ChEMBL | Inhibition of FGFR3 kinase domain using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
fibroblast growth factor receptor 4/Fibroblast growth factor receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3973] [GtoPdb: 1811] [UniProtKB: P22455] | ||||||||
ChEMBL | Inhibition of FGFR4 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
protein tyrosine kinase 2/Focal adhesion kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2695] [GtoPdb: 2180] [UniProtKB: Q05397] | ||||||||
ChEMBL | Inhibition of FAK using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
ChEMBL | Inhibition of GSK3-beta using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
MET proto-oncogene, receptor tyrosine kinase/Hepatocyte growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3717] [GtoPdb: 1815] [UniProtKB: P08581] | ||||||||
ChEMBL | Inhibition of cMET using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Insulin-like growth factor I receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1957] [GtoPdb: 1801] [UniProtKB: P08069] | ||||||||
ChEMBL | Inhibition of IGF1R using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Insulin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1981] [GtoPdb: 1800] [UniProtKB: P06213] | ||||||||
ChEMBL | Inhibition of Ins1R using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
interleukin 1 receptor associated kinase 4/Interleukin-1 receptor-associated kinase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3778] [GtoPdb: 2045] [UniProtKB: Q9NWZ3] | ||||||||
ChEMBL | Inhibition of IRAK4 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
macrophage stimulating 1 receptor/Macrophage-stimulating protein receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2689] [GtoPdb: 1816] [UniProtKB: Q04912] | ||||||||
ChEMBL | Inhibition of RON using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
MAPK activated protein kinase 2/MAP kinase-activated protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2208] [GtoPdb: 2094] [UniProtKB: P49137] | ||||||||
ChEMBL | Inhibition of MK2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
MAPK activated protein kinase 5/MAP kinase-activated protein kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3094] [GtoPdb: 2096] [UniProtKB: Q8IW41] | ||||||||
ChEMBL | Inhibition of MK5 using ATP as substrate | B | 5.77 | pIC50 | 1700 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
mitogen-activated protein kinase 1/MAP kinase ERK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4040] [GtoPdb: 1495] [UniProtKB: P28482] | ||||||||
ChEMBL | Inhibition of ERK2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
mitogen-activated protein kinase 14/MAP kinase p38 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL260] [GtoPdb: 1499] [UniProtKB: Q16539] | ||||||||
ChEMBL | Inhibition of p38alpha using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
mitogen-activated protein kinase kinase kinase 8/Mitogen-activated protein kinase kinase kinase 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4899] [GtoPdb: 2083] [UniProtKB: P41279] | ||||||||
ChEMBL | Inhibition of COT1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
phosphatidylinositol 3-kinase catalytic subunit type 3/Phosphatidylinositol 3-kinase catalytic subunit type 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075165] [GtoPdb: 2152] [UniProtKB: Q8NEB9] | ||||||||
ChEMBL | Inhibition of VPS34 using ATP as substrate | B | 5.04 | pIC50 | >9100 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336] | ||||||||
ChEMBL | Inhibition of PI3Kalpha using ATP as substrate | B | 5.04 | pIC50 | >9100 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338] | ||||||||
ChEMBL | Inhibition of PI3Kbeta using ATP as substrate | B | 5.07 | pIC50 | 8600 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/PI3-kinase p110-delta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3130] [GtoPdb: 2155] [UniProtKB: O00329] | ||||||||
ChEMBL | Inhibition of PI3Kdelta using ATP as substrate | B | 5.33 | pIC50 | 4700 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
ChEMBL | Inhibition of PI3Kgamma using ATP as substrate | B | 5.51 | pIC50 | 3100 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
phosphatidylinositol 4-kinase beta/PI4-kinase beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3268] [GtoPdb: 2149] [UniProtKB: Q9UBF8] | ||||||||
ChEMBL | Inhibition of PI4Kbeta using ATP as substrate | B | 5.6 | pIC50 | 2500 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
platelet derived growth factor receptor alpha/Platelet-derived growth factor receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2007] [GtoPdb: 1803] [UniProtKB: P16234] | ||||||||
ChEMBL | Inhibition of PDGFRalpha using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
protein kinase C alpha/Protein kinase C alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL299] [GtoPdb: 1482] [UniProtKB: P17252] | ||||||||
ChEMBL | Inhibition of PKCalpha using ATP as substrate | B | 5.66 | pIC50 | 2200 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
protein kinase C theta/Protein kinase C theta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3920] [GtoPdb: 1488] [UniProtKB: Q04759] | ||||||||
ChEMBL | Inhibition of PKCtheta using ATP as substrate | B | 5.85 | pIC50 | 1400 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
protein kinase N1/Protein kinase N1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3384] [GtoPdb: 1520] [UniProtKB: Q16512] | ||||||||
ChEMBL | Inhibition of PKN1 using ATP as substrate | B | 6.51 | pIC50 | 310 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
GtoPdb | - | - | 6.51 | pIC50 | 310 | nM | IC50 | J Med Chem (2012) 55: 403-13 [PMID:22136433] |
protein kinase N2/Protein kinase N2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3032] [GtoPdb: 1521] [UniProtKB: Q16513] | ||||||||
ChEMBL | Inhibition of PKN2 using ATP as substrate | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
erb-b2 receptor tyrosine kinase 2/Receptor protein-tyrosine kinase erbB-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1824] [GtoPdb: 2019] [UniProtKB: P04626] | ||||||||
ChEMBL | Inhibition of HER2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
ChEMBL | Inhibition of HER4 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Rho associated coiled-coil containing protein kinase 2/Rho-associated protein kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2973] [GtoPdb: 1504] [UniProtKB: O75116] | ||||||||
ChEMBL | Inhibition of ROCK2 using ATP as substrate | B | 6.66 | pIC50 | 220 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
ChEMBL | Inhibition of PKBalpha using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
aurora kinase A/Serine/threonine-protein kinase Aurora-A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4722] [GtoPdb: 1936] [UniProtKB: O14965] | ||||||||
ChEMBL | Inhibition of Aurora A using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2842] [GtoPdb: 2109] [UniProtKB: P42345] | ||||||||
ChEMBL | Inhibition of mTOR using ATP as substrate | B | 5.04 | pIC50 | >9100 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
p21 (RAC1) activated kinase 2/Serine/threonine-protein kinase PAK 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4487] [GtoPdb: 2134] [UniProtKB: Q13177] | ||||||||
ChEMBL | Inhibition of PAK2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Pim-1 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase PIM1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2147] [GtoPdb: 2158] [UniProtKB: P11309] | ||||||||
GtoPdb | - | - | 7.22 | pIC50 | 60 | nM | IC50 | J Med Chem (2012) 55: 403-13 [PMID:22136433] |
ChEMBL | Inhibition of PIM1 using ATP as substrate | B | 7.22 | pIC50 | 60 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Pim-2 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase PIM2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523] [GtoPdb: 2159] [UniProtKB: Q9P1W9] | ||||||||
ChEMBL | Inhibition of PIM2 using ATP as substrate | B | 6.62 | pIC50 | 240 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Pim-3 proto-oncogene, serine/threonine kinase/Serine/threonine-protein kinase PIM3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5407] [GtoPdb: 2160] [UniProtKB: Q86V86] | ||||||||
ChEMBL | Inhibition of PIM3 using ATP as substrate | B | 7.05 | pIC50 | 90 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
GtoPdb | - | - | 7.05 | pIC50 | 90 | nM | IC50 | J Med Chem (2012) 55: 403-13 [PMID:22136433] |
polo like kinase 1/Serine/threonine-protein kinase PLK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3024] [GtoPdb: 2168] [UniProtKB: P53350] | ||||||||
ChEMBL | Inhibition of PLK1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
WNK lysine deficient protein kinase 1/Serine/threonine-protein kinase WNK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075173] [GtoPdb: 2280] [UniProtKB: Q9H4A3] | ||||||||
ChEMBL | Inhibition of WNK1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
KIT proto-oncogene, receptor tyrosine kinase/Stem cell growth factor receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1936] [GtoPdb: 1805] [UniProtKB: P10721] | ||||||||
ChEMBL | Inhibition of cKIT using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
ABL proto-oncogene 1, non-receptor tyrosine kinase/Tyrosine-protein kinase ABL in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1862] [GtoPdb: 1923] [UniProtKB: P00519] | ||||||||
ChEMBL | Inhibition of cABL using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
ChEMBL | Inhibition of cABL T315I mutant using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
C-terminal Src kinase/Tyrosine-protein kinase CSK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2634] [GtoPdb: 1994] [UniProtKB: P41240] | ||||||||
ChEMBL | Inhibition of CSK using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
FYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase FYN in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1841] [GtoPdb: 2026] [UniProtKB: P06241] | ||||||||
ChEMBL | Inhibition of FYN using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
HCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase HCK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3234] [GtoPdb: 2032] [UniProtKB: P08631] | ||||||||
ChEMBL | Inhibition of HCK using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Janus kinase 1/Tyrosine-protein kinase JAK1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2835] [GtoPdb: 2047] [UniProtKB: P23458] | ||||||||
ChEMBL | Inhibition of JAK1 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Janus kinase 2/Tyrosine-protein kinase JAK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2971] [GtoPdb: 2048] [UniProtKB: O60674] | ||||||||
ChEMBL | Inhibition of JAK2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Janus kinase 3/Tyrosine-protein kinase JAK3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2148] [GtoPdb: 2049] [UniProtKB: P52333] | ||||||||
ChEMBL | Inhibition of JAK3 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
LCK proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase LCK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL258] [GtoPdb: 2053] [UniProtKB: P06239] | ||||||||
ChEMBL | Inhibition of LCK using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
LYN proto-oncogene, Src family tyrosine kinase/Tyrosine-protein kinase Lyn in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3905] [GtoPdb: 2060] [UniProtKB: P07948] | ||||||||
ChEMBL | Inhibition of LYN using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
fms related receptor tyrosine kinase 3/Tyrosine-protein kinase receptor FLT3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1974] [GtoPdb: 1807] [UniProtKB: P36888] | ||||||||
ChEMBL | Inhibition of FLT3 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
ret proto-oncogene/Tyrosine-protein kinase receptor RET in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2041] [GtoPdb: 2185] [UniProtKB: P07949] | ||||||||
ChEMBL | Inhibition of RET using ATP as substrate | B | 5.11 | pIC50 | 7700 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
AXL receptor tyrosine kinase/Tyrosine-protein kinase receptor UFO in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4895] [GtoPdb: 1835] [UniProtKB: P30530] | ||||||||
ChEMBL | Inhibition of AXL using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
SRC proto-oncogene, non-receptor tyrosine kinase/Tyrosine-protein kinase SRC in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL267] [GtoPdb: 2206] [UniProtKB: P12931] | ||||||||
ChEMBL | Inhibition of cSRC using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
spleen associated tyrosine kinase/Tyrosine-protein kinase SYK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2599] [GtoPdb: 2230] [UniProtKB: P43405] | ||||||||
ChEMBL | Inhibition of SYK using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
tyrosine kinase 2/Tyrosine-protein kinase TYK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3553] [GtoPdb: 2269] [UniProtKB: P29597] | ||||||||
ChEMBL | Inhibition of TYK2 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
YES proto-oncogene 1, Src family tyrosine kinase/Tyrosine-protein kinase YES in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073] [GtoPdb: 2284] [UniProtKB: P07947] | ||||||||
ChEMBL | Inhibition of YES using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
zeta chain of T cell receptor associated protein kinase 70/Tyrosine-protein kinase ZAP-70 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2803] [GtoPdb: 2285] [UniProtKB: P43403] | ||||||||
ChEMBL | Inhibition of ZAP70 using ATP as substrate | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
kinase insert domain receptor/Vascular endothelial growth factor receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL279] [GtoPdb: 1813] [UniProtKB: P35968] | ||||||||
ChEMBL | Inhibition of KDR using ATP as substrate | B | 5.14 | pIC50 | 7200 | nM | IC50 | J Med Chem (2012) 55: 403-413 [PMID:22136433] |
Calmodulin-dependent kinase II in Human [GtoPdb: 1554] | ||||||||
GtoPdb | - | - | 7.08 | pIC50 | 83 | nM | IC50 | J Med Chem (2012) 55: 403-13 [PMID:22136433] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]